Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2016

Open Access 01-12-2016 | Research

Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness

Authors: Alex H. S. Harris, Thomas Bowe, Hildi Hagedorn, Andrea Nevedal, Andrea K. Finlay, Risha Gidwani, Craig Rosen, Chad Kay, Melissa Christopher

Published in: Addiction Science & Clinical Practice | Issue 1/2016

Login to get access

Abstract

Background

Active consideration of effective medications to treat alcohol use disorder (AUD) is a consensus standard of care, yet knowledge and use of these medications are very low across diverse settings. This study evaluated the overall effectiveness a multifaceted academic detailing program to address this persistent quality problem in the US Veterans Health Administration (VHA), as well as the context and process factors that explained variation in effectiveness across sites.

Methods

An interrupted time series design, analyzed with mixed-effects segmented logistic regression, was used to evaluate changes in level and rate of change in the monthly percent of patients with a clinically documented AUD who received naltrexone, acamprosate, disulfiram, or topiramate. Using data from a 20 month post-implementation period, intervention sites (n = 37) were compared to their own 16 month pre-implementation performance and separately to the rest of VHA.

Results

From immediately pre-intervention to the end of the observation period, the percent of patients in the intervention sites with AUD who received medication increased over 3.4 % in absolute terms and 68 % in relative terms (i.e., 4.9–8.3 %). This change was significant compared to the pre-implementation period in the intervention sites and secular trends in control sites. Sites with lower pre-implementation adoption, more person hours of detailing, but fewer people detailed, had larger immediate increases in medication receipt after implementation. The average number of detailing encounters per person was associated with steeper increases in slope over time.

Conclusions

This study found empirical support for a multifaceted quality improvement strategy aimed at increasing access to and utilization of pharmacotherapy for AUD. Future studies should focus on determining how to enhance the programs effects, especially in non-responsive locations.
Literature
1.
go back to reference Blodgett JC, Del Re AC, Maisel NC, et al. A meta-analysis of topiramate’s effects for individuals with alcohol use disorders. Alcohol Clin Exp Res. 2014;38:1481–8.CrossRefPubMedPubMedCentral Blodgett JC, Del Re AC, Maisel NC, et al. A meta-analysis of topiramate’s effects for individuals with alcohol use disorders. Alcohol Clin Exp Res. 2014;38:1481–8.CrossRefPubMedPubMedCentral
2.
go back to reference Maisel NC, Blodgett JC, Wilbourne PL, et al. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction. 2013;108:275–93.CrossRefPubMed Maisel NC, Blodgett JC, Wilbourne PL, et al. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction. 2013;108:275–93.CrossRefPubMed
3.
go back to reference Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311:1889–900.CrossRefPubMed Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311:1889–900.CrossRefPubMed
4.
go back to reference Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009;70:516–27.CrossRefPubMedPubMedCentral Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009;70:516–27.CrossRefPubMedPubMedCentral
5.
go back to reference Riper H, Andersson G, Hunter SB, et al. Treatment of comorbid alcohol use disorders and depression with cognitive–behavioural therapy and motivational interviewing: a meta-analysis. Addiction. 2014;109:394–406.CrossRefPubMedPubMedCentral Riper H, Andersson G, Hunter SB, et al. Treatment of comorbid alcohol use disorders and depression with cognitive–behavioural therapy and motivational interviewing: a meta-analysis. Addiction. 2014;109:394–406.CrossRefPubMedPubMedCentral
7.
go back to reference Ducharme LJ, Chandler RK, Harris AHS. Implementing substance abuse treatment in general medical settings: mapping the research terrain. J Subst Abuse Treat. 2016;60:110–8.CrossRefPubMed Ducharme LJ, Chandler RK, Harris AHS. Implementing substance abuse treatment in general medical settings: mapping the research terrain. J Subst Abuse Treat. 2016;60:110–8.CrossRefPubMed
8.
go back to reference Harris AH, Ellerbe L, Reeder RN, et al. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. Psychol Serv. 2013;10:410–9.CrossRefPubMed Harris AH, Ellerbe L, Reeder RN, et al. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. Psychol Serv. 2013;10:410–9.CrossRefPubMed
9.
go back to reference Harris AH, Kivlahan DR, Bowe T, et al. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr Serv. 2010;61:392–8.CrossRefPubMed Harris AH, Kivlahan DR, Bowe T, et al. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr Serv. 2010;61:392–8.CrossRefPubMed
10.
go back to reference Mark TL, Kassed CA, Vandivort-Warren R, et al. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend. 2009;99:345–9.CrossRefPubMed Mark TL, Kassed CA, Vandivort-Warren R, et al. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend. 2009;99:345–9.CrossRefPubMed
11.
go back to reference Ducharme LJ, Knudsen HK, Roman PM. Trends in the adoption of medications for alcohol dependence. J Clin Psychopharmacol. 2006;26(Suppl. 1):S13–9.CrossRefPubMed Ducharme LJ, Knudsen HK, Roman PM. Trends in the adoption of medications for alcohol dependence. J Clin Psychopharmacol. 2006;26(Suppl. 1):S13–9.CrossRefPubMed
12.
go back to reference Knudsen HK, Roman PM. Service delivery and pharmacotherapy for alcohol use disorder in the era of health reform: data from a national sample of treatment organizations. Subst Abus. 2016;37:230–7.CrossRefPubMed Knudsen HK, Roman PM. Service delivery and pharmacotherapy for alcohol use disorder in the era of health reform: data from a national sample of treatment organizations. Subst Abus. 2016;37:230–7.CrossRefPubMed
13.
go back to reference Rubinsky AD, Chen C, Batki SL, et al. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses. J Psychiatr Res. 2015;69:150–7.CrossRefPubMed Rubinsky AD, Chen C, Batki SL, et al. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses. J Psychiatr Res. 2015;69:150–7.CrossRefPubMed
14.
go back to reference The Management of Substance Use Disorders Working Group. VA/DOD clinical practice guideline for the management of substance use disorders. Washington, DC: US Department of Veterans Affairs and Department of Defense; 2009. The Management of Substance Use Disorders Working Group. VA/DOD clinical practice guideline for the management of substance use disorders. Washington, DC: US Department of Veterans Affairs and Department of Defense; 2009.
15.
go back to reference Harris AH, Oliva E, Bowe T, et al. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence. Psychiatr Serv. 2012;63:679–85.CrossRefPubMed Harris AH, Oliva E, Bowe T, et al. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence. Psychiatr Serv. 2012;63:679–85.CrossRefPubMed
16.
go back to reference Trafton JA, Greenberg G, Harris AH, et al. VHA mental health information system: applying health information technology to monitor and facilitate implementation of VHA uniform mental health services handbook requirements. Med Care. 2013;51:S29–36.CrossRefPubMed Trafton JA, Greenberg G, Harris AH, et al. VHA mental health information system: applying health information technology to monitor and facilitate implementation of VHA uniform mental health services handbook requirements. Med Care. 2013;51:S29–36.CrossRefPubMed
17.
go back to reference O’Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, Forsetlund L, Bainbridge D, Freemantle N, Davis DA, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007;(4):CD000409. O’Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, Forsetlund L, Bainbridge D, Freemantle N, Davis DA, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007;(4):CD000409.
18.
go back to reference Bidassie B, Williams LS, Woodward-Hagg H, et al. Key components of external facilitation in an acute stroke quality improvement collaborative in the Veterans Health Administration. Implement Sci. 2015;10:69.CrossRefPubMedPubMedCentral Bidassie B, Williams LS, Woodward-Hagg H, et al. Key components of external facilitation in an acute stroke quality improvement collaborative in the Veterans Health Administration. Implement Sci. 2015;10:69.CrossRefPubMedPubMedCentral
19.
go back to reference Stetler CB, Legro MW, Rycroft-Malone J, et al. Role of “external facilitation” in implementation of research findings: a qualitative evaluation of facilitation experiences in the Veterans Health Administration. Implement Sci. 2006;1:23.CrossRefPubMedPubMedCentral Stetler CB, Legro MW, Rycroft-Malone J, et al. Role of “external facilitation” in implementation of research findings: a qualitative evaluation of facilitation experiences in the Veterans Health Administration. Implement Sci. 2006;1:23.CrossRefPubMedPubMedCentral
20.
go back to reference Schwartz TL, Kuhles DJ 2nd, Wade M, et al. Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits. Ann Clin Psychiatry. 2001;13:159–62.CrossRefPubMed Schwartz TL, Kuhles DJ 2nd, Wade M, et al. Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits. Ann Clin Psychiatry. 2001;13:159–62.CrossRefPubMed
21.
go back to reference Espallargues M, Valderas JM, Alonso J. Provision of feedback on perceived health status to health care professionals: a systematic review of its impact. Med Care. 2000;38:175–86.CrossRefPubMed Espallargues M, Valderas JM, Alonso J. Provision of feedback on perceived health status to health care professionals: a systematic review of its impact. Med Care. 2000;38:175–86.CrossRefPubMed
22.
go back to reference Duncan T, Duncan S. A latent growth curve modeling approach to pooled interrupted time series analysis. J Psychopathol Behav Assess. 2004;26:271–8.CrossRef Duncan T, Duncan S. A latent growth curve modeling approach to pooled interrupted time series analysis. J Psychopathol Behav Assess. 2004;26:271–8.CrossRef
23.
go back to reference Finney JW. Regression to the mean in substance use disorder treatment research. Addiction. 2008;103:42–52.CrossRefPubMed Finney JW. Regression to the mean in substance use disorder treatment research. Addiction. 2008;103:42–52.CrossRefPubMed
Metadata
Title
Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness
Authors
Alex H. S. Harris
Thomas Bowe
Hildi Hagedorn
Andrea Nevedal
Andrea K. Finlay
Risha Gidwani
Craig Rosen
Chad Kay
Melissa Christopher
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Addiction Science & Clinical Practice / Issue 1/2016
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-016-0063-8

Other articles of this Issue 1/2016

Addiction Science & Clinical Practice 1/2016 Go to the issue